Our firm is deeply invested in your business. We find leaders worldwide for the energy and chemical value chain, life sciences, advanced industrial solutions and consumer packaged goods sectors.
Our partners offer a confidential space for candid dialogue rooted in real-world executive experience. Clarity, candour and insight, with a human touch.
Over 1,500 executives placed by Borderless have become leaders in their industries, and we’re proud of their achievements. However, our ambition doesn’t stop there. We continually strive to positively impact the lives of the thousands we engage with annually.
Building a deep understanding of your unique business and personal goals is key to our approach. Our team, drawing from diverse backgrounds as international executives in your sector, is well-equipped to facilitate meaningful conversations, foster connections, and accelerate your success.
Clients across the energy sector and chemical value chain know they can rely on our executive search expertise and industry know-how.
From start-ups to established corporations, we assist clients across the life sciences sector to attract forward-looking leaders.
Makers of high protein foods, the world’s favourite beer, household and personal care products and packaging look to us to find leaders in tune with consumer trends.
Companies at the forefront of industrial automation, digital services, and Industry 4.0 initiatives rely on Borderless as a dependable ally to find and attract exceptional executives.
Tell us more about yourself, your career and your aspirations.
We truly think and act in a borderless way.
We care about your career and your business. No border can stop us from finding the perfect match or solution.
I believe the best leadership decisions start with a deep understanding of the business, where it is going, what needs to change and the kind of people who will make that happen.
That is the...
When the right candidate meets the right role, great things happen! This belief drives me to find the right match and has consistently placed my firm and me in the top 5% ...
My ambition is to constantly make a difference to companies and organisations and thereby contribute to the progress of a sustainable, diverse society. Making that difference is my passion and livi...
I am fascinated why people embark on fresh adventures and how and why organizations aspire to contribute to the world. I guide executives and companies in turning their dreams to reality and transf...
I have spent more than forty years learning how organisations and the people inside them actually work. Not in theory, and not from a distance, but through the kind ...
I am passionate about Life Sciences and understanding how large organizations function. I have close to 10 years’ experience as a consultant advising both publ...
If you asked the people I have worked alongside to describe me, two words would come up more than any others: energy and persistence. I have done my best...
I am an experienced HR professional and have worked for a diverse range of industrial companies in a variety of corporate environments in Brazil. Since the beginning of ...
I have more than 10 years of experience in executive search for the Life Sciences sector across multiple geographies. His exposure to the sector and its decision-makers has been instrumental in bui...
My lived experiences are eclectic, unconventional, messy even. Full of reinvention and curiosity.
I have worn many hats over the years in as many different places. Pharmacist-Researcher-Sale...
I have devoted my career to finding and attracting talented executives for senior roles. I bring to the table a diverse portfolio of experiences spanning various sector...
What drives someone to love their work or quietly disengage from it? That question has shaped the past 20 years of my career, and it still fascinates me every day.
I work at the intersection...
Sika AG said Aug. 19 that it has placed an inaugural hybrid capital bond with a total amount of €1 billion split into two €500-million tranches. The net proceeds of the transaction will be used for general corporate purposes including financing of bolt-on acquisitions and refinancing of existing financial indebtedness, the company said.
LEO Pharma has agreed to buy the worldwide rights to Tanabe Pharma’s drug in development for photosensitive genetic disorder treatment, bolstering the Danish company’s pipeline that has already undergone expansion this year.
DSM-Firmenich’s chair of the board of directors, Thomas Leysen (pictured above), has decided to retire from his role once his successor has been elected by the company’s shareholders. The company said its ‘strategic direction’ is ‘fully set,’ prompting Leysen’s decision to step down and devote more time to his other corporate and non-profit mandates.
Packaging group SIG has announced that its chief financial officer, Ann-Kristin Erkens, will take on the role of chief executive officer, effective immediately. Erkens previously served as SIG’s interim CEO from August 2025 to end of February 2026. She will take over from current CEO Mikko Keto, who took up the position in spring 2026, and will continue to serve as CFO until a successor has been appointed.
